Parallax Volatility Advisers, L.P. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$1,103,850
+5.4%
45,000
-0.0%
0.00%0.0%
Q1 2023$1,047,243
-34.3%
45,004
+18.2%
0.00%
+100.0%
Q4 2021$1,595,000
-51.8%
38,090
-45.6%
0.00%
-66.7%
Q2 2021$3,310,000
+257.5%
70,000
+102.4%
0.00%
+200.0%
Q4 2020$926,00034,5870.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders